Importer of Controlled Substances; Notice of Registration, 6580 [E7-2330]
Download as PDF
<![CDATA[
6580
Federal Register / Vol. 72, No. 28 / Monday, February 12, 2007 / Notices
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative/ODL; or
any being sent via express mail should
be sent to DEA Headquarters, Attention:
DEA Federal Register Representative/
ODL, 2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than April 13, 2007.
Dated: February 5, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–2330 Filed 2–9–07; 8:45 am]
Dated: February 5, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–2320 Filed 2–9–07; 8:45 am]
Drug Enforcement Administration
BILLING CODE 4410–09–P
Introduction and Procedural History
This is a consolidated proceeding. On
November 7, 2001, the then
Administrator of the Drug Enforcement
Administration, issued an Order to
Show Cause and Notice of Immediate
Suspension of the practitioner’s
Certificate of Registration, AC1643661,
issued to Edmund Chein, M.D.
(Respondent) of Palm Springs,
California. The Notice of Immediate
Suspension was based on the
Administrator’s preliminary conclusion
that Respondent’s continued registration
constituted ‘‘an imminent danger to the
public health and safety because of the
substantial likelihood that [Respondent
would] continue exporting and
diverting controlled substances.’’ Order
to Show Cause and Notice of Immediate
Suspension at 6 (2001 OSC). The Order
further proposed to revoke Respondent’s
practitioner’s registration and deny any
pending applications for renewal of the
registration on the ground that
Respondent’s continued registration
would be inconsistent with the public
interest. See id. at 1; see also 21 U.S.C.
823(f) & 824(a)(4).
Subsequently, on May 24, 2002, the
Deputy Assistant Administrator, Office
of Diversion Control, issued an
additional Order to Show Cause
(hereinafter 2002 OSC) to Respondent.
This Show Cause Order proposed to
deny Respondent’s pending application
for a registration as an exporter on the
ground that issuance of a registration
would be inconsistent with the public
interest. 2002 OSC at 1; see also 21
U.S.C. 958(c) &(d); id. 823(d).
The 2001 OSC alleged that
Respondent had purchased ‘‘large
amounts of anabolic steroids’’ from a
Mexican pharmacy and ‘‘other
illegitimate sources’’ and had
distributed these substances to
individuals who did not have a
legitimate medical need for them. 2001
OSC at 2. The OSC further alleged that
on May 28, 1996, Federal agents
Edmund Chein, M.D.; Revocation of
Practitioner’s Registration, Denial of
Application for Exporter’s Registration
Drug Enforcement Administration
sroberts on PROD1PC70 with NOTICES
Importer of Controlled Substances;
Notice of Registration
By Notice dated October 12, 2006 and
published in the Federal Register on
October 19, 2006, (71 FR 61800–61801),
Tocris Cookson, Inc., 16144 Westwoods
Business Park, Ellisville, Missouri
63021–7683, made application by letter
to the Drug Enforcement Administration
(DEA) to be registered as an importer of
Marihuana (7360), a basic class of
controlled substance listed in schedule
I.
The company plans to import this
product for non-clinical laboratory
based research only.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. § 823(a) and 952(a)
and determined that the registration of
Tocris Cookson, Inc. to import the basic
class of controlled substance is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated Tocris
Cookson, Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substance
listed.
19:52 Feb 09, 2007
Jkt 211001
DEPARTMENT OF JUSTICE
[Docket Nos. 02–09, 02–43]
DEPARTMENT OF JUSTICE
VerDate Aug<31>2005
BILLING CODE 4410–09–P
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
executed a search warrant at
Respondent’s medical office and seized
several vials of steroids for which there
were no records. Id. The OSC further
alleged that in June 1996, DEA obtained
from Henry Schein, Inc., copies of
invoices which documented that
Respondent had purchased controlled
substances on nine different occasions
between January 1995 and May 1996. Id.
at 3. The OSC alleged that Respondent
had failed to keep accurate records of
the purchase, inventory, and
dispensation of controlled substances.
Id.
The 2001 OSC next alleged that on
January 31, 2001, DEA Diversion
Investigators (DIs) went to Respondent’s
Palm Springs medical office, the Palm
Springs Life Extension Institute
(hereinafter PSLEI), to conduct an
administrative inspection. Id. The OSC
alleged that the invoices documenting
the purchases of controlled substances
were at an accounting firm and not at
the office. Id. The 2001 OSC further
alleged that ‘‘none of [the] required
controlled substance records were
accessible,’’ because the records were
stored in a computer and none of the
office personnel then present were
capable of retrieving them. Id. The OSC
thus alleged that Respondent had
violated the Controlled Substance Act
by failing ‘‘to maintain in a readily
available condition’’ initial and biennial
inventory records, purchase invoices,
and dispensing records. Id.
The 2001 OSC further alleged that on
February 5, 2001, DEA personnel
returned to Respondent’s office and
obtained an inventory of controlled
substances that was dated February 5,
2001, dispensing records for the period
July 1, 2000, through February 1, 2001,
and invoices for purchases of controlled
substances from Barnes Wholesale, Inc.,
for the period January 1, 1999, through
February 4, 2001. Id. The OSC also
alleged that the dispensing records
showed that between July 1, 2000, and
February 5, 2001, Respondent dispensed
anabolic steroids, a Schedule III
controlled substance, and phentermine,
a Schedule IV controlled substance, to
persons in Korea, Belgium, Indonesia,
Canada, Japan, Spain, Germany,
Switzerland, Mexico, England, and
Hong Kong. Id. at 3–4.
More specifically, the OSC alleged
that Respondent had made 328 illegal
exports comprised of 20 exports of
phentermine 30 mg., 58 exports of
phentermine 15 mg., 73 exports of
testosterone gel 8 mg., 12 exports of
testosterone gel 100 mg., 50 exports of
testosterone estradiol gel 4 mg, 113
exports of Depo testosterone 200 mg.,
and two exports of testosterone 50 mg.
E:\FR\FM\12FEN1.SGM
12FEN1
]]>Agencies
[Federal Register Volume 72, Number 28 (Monday, February 12, 2007)]
[Notices]
[Page 6580]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-2330]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated October 12, 2006 and published in the Federal
Register on October 19, 2006, (71 FR 61800-61801), Tocris Cookson,
Inc., 16144 Westwoods Business Park, Ellisville, Missouri 63021-7683,
made application by letter to the Drug Enforcement Administration (DEA)
to be registered as an importer of Marihuana (7360), a basic class of
controlled substance listed in schedule I.
The company plans to import this product for non-clinical
laboratory based research only.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. Sec. 823(a) and 952(a) and determined that
the registration of Tocris Cookson, Inc. to import the basic class of
controlled substance is consistent with the public interest and with
United States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971, at this time. DEA has investigated
Tocris Cookson, Inc. to ensure that the company's registration is
consistent with the public interest. The investigation has included
inspection and testing of the company's physical security systems,
verification of the company's compliance with state and local laws, and
a review of the company's background and history. Therefore, pursuant
to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34,
the above named company is granted registration as an importer of the
basic class of controlled substance listed.
Dated: February 5, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E7-2330 Filed 2-9-07; 8:45 am]
BILLING CODE 4410-09-P
